Re-imagine, Re-invent, Transform

Dr. Paul Klotman
 President and CEO
Baylor College of Medicine

Monthly Theme: Business Reinvention

Thursday, June 9, 2011 

Reinventing an organization is one of the toughest challenges, especially if it is has been around for over a hundred years, and has been significantly successful.

With an operating budget exceeding $1 billion and total research support of $400 million, Baylor College of Medicine (BCM) ranked as one of the top 25 medical schools for research in U.S. News & World Report's America's Best Graduate Schools 2012. BCM patient care services extend to 17 institutions in Houston, reaching more than 131,000 inpatients and 1.9 million outpatients annually. Baylor is one of the six institutions designated by the National Institutes of Health as a Vaccine Evaluation Unit and is a site of the Human Genome Project.

Dr. Klotman took over as CEO less than twelve months ago. He is leading an inspired charge to reinvent Baylor so it will thrive in the 21st century Healthcare model, and he is transforming Baylor into a global player. Come understand how he is reimagining and reinventing a well-established organization.

Dr. Paul Klotman began serving as president and CEO of Baylor College of Medicine on Sept. 1, 2010. He received his B.S. degree in 1972 from the University of Michigan and his M.D. from Indiana University in 1976. He completed his medicine and nephrology training at Duke University Medical Center. He stayed at Duke as a faculty member, rising to the rank of associate professor of medicine before moving to the NIH in 1988 where he became chief of the Molecular Medicine Section in the Laboratory of Developmental Biology. In 1993, he became chief of the Viral Pathogenesis Laboratory in the NIDR/NIH. In 1994, he moved to Mt. Sinai School of Medicine as the Irene and Dr. Arthur M. Fishberg Professor of Medicine and the chief of the Division of Nephrology. In 2001, he was selected to be the chair of the Samuel Bronfman Department of Medicine of the Mt. Sinai School of Medicine. The BCM Board of Trustees named him as the school’s new president in July of 2010.

Dr. Klotman's research has been a blend of both basic and clinical research in molecular virology and AIDS pathogenesis. He developed the first small animal model of HIV associated nephropathy using transgenic techniques.He is the author of more than 200 publications and he has been a visiting professor and lecturer internationally in the field of HIV pathogenesis. He has been elected to both the American Society of Clinical Investigation and the Association of American Physicians. He is on the editorial boards of journals both in the United States and in Europe and he has served on and chaired numerous study sections including those from the NIH, the American Heart Association, the National Kidney Foundation, and the VA research service. He currently leads the Association of Professors of Medicine efforts in improving the training and mentoring of Physician Scientists.

In addition to his laboratory efforts, Dr. Klotman has been an active clinician, teacher, and mentor. Students from his laboratory have won prestigious scientific competitions. He has trained over 50 clinical fellows, postdoctoral fellows, and students in his laboratory since 1984 most of whom are independently funded. Four of his mentees are now chairs of medicine and four others lead major institutes or centers. He has been listed in both Castle Connelly and New York Magazine as one of the region's Best Doctors. And, he was named Physician of the Year by Mt. Sinai nurses. As the chair of medicine, he moved the Department of Medicine at Mt. Sinai to a top tier academic program by expanding the Faculty Practice, increasing basic and clinical research revenues, developing new community projects, and focusing on the educational mission.

Dr. Klotman serves on the scientific advisory boards of biotech, pharmaceutical, and health care companies. He also serves on the board of several companies including those with interests in natural resources and conservation.

At Baylor College of Medicine, he oversees the only private medical school in the Greater Southwest, with research funding of more than $323 million. The college is ranked as one of the top 25 medical schools for research by U.S. News & World Report and is ranked second among all Texas colleges, universities and medical schools in federal funding for research and development.